{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T21:09:39Z","timestamp":1782421779259,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T00:00:00Z","timestamp":1339891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10552-012-0011-1","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T10:07:31Z","timestamp":1340014051000},"page":"1323-1331","source":"Crossref","is-referenced-by-count":21,"title":["Liquid-based cervical cytology using ThinPrep technology: weighing the pros and cons in a cost-effectiveness analysis"],"prefix":"10.1007","volume":"23","author":[{"given":"Esther W.","family":"de Bekker-Grob","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge M. C. M.","family":"de Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Bulten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"van Rosmalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith E. M.","family":"Vedder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Arbyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J. J. M.","family":"Klinkhamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertus G.","family":"Siebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"van Ballegooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,17]]},"reference":[{"issue":"5","key":"11_CR1","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1023\/A:1018435522475","volume":"8","author":"L Gustafsson","year":"1997","unstructured":"Gustafsson L, Ponten J, Zack M, Adami HO (1997) International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8(5):755\u2013763","journal-title":"Cancer Causes Control"},{"issue":"3","key":"11_CR2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ygyno.2008.12.012","volume":"112","author":"H Beerman","year":"2009","unstructured":"Beerman H, van Dorst EB, Kuenen-Boumeester V, Hogendoorn PC (2009) Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program. Gynecol Oncol 112(3):572\u2013576","journal-title":"Gynecol Oncol"},{"issue":"3","key":"11_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2303.2007.00464.x","volume":"18","author":"M Arbyn","year":"2007","unstructured":"Arbyn M, Herbert A, Schenck U, Nieminen P, Jordan J, McGoogan E et al (2007) European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 18(3):133\u2013139","journal-title":"Cytopathology"},{"issue":"1","key":"11_CR4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","volume":"111","author":"M Arbyn","year":"2008","unstructured":"Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J (2008) Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 111(1):167\u2013177","journal-title":"Obstet Gynecol"},{"issue":"9505","key":"11_CR5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0140-6736(06)67961-0","volume":"367","author":"E Davey","year":"2006","unstructured":"Davey E, Barratt A, Irwig L, Chan SF, Macaskill P, Mannes P et al (2006) Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet 367(9505):122\u2013132","journal-title":"Lancet"},{"issue":"7609","key":"11_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bmj.39196.740995.BE","volume":"335","author":"G Ronco","year":"2007","unstructured":"Ronco G, Cuzick J, Pierotti P, Cariaggi MP, Dalla Palma P, Naldoni C et al (2007) Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ 335(7609):28","journal-title":"BMJ"},{"issue":"16","key":"11_CR7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","volume":"302","author":"AG Siebers","year":"2009","unstructured":"Siebers AG, Klinkhamer PJ, Grefte JM, Massuger LF, Vedder JE, Beijers-Broos A et al (2009) Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial. JAMA 302(16):1757\u20131764","journal-title":"JAMA"},{"issue":"6","key":"11_CR8","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/AOG.0b013e31818c2b20","volume":"112","author":"AG Siebers","year":"2008","unstructured":"Siebers AG, Klinkhamer PJ, Arbyn M, Raifu AO, Massuger LF, Bulten J (2008) Cytologic detection of cervical abnormalities using liquid-based compared with conventional cytology: a randomized controlled trial. Obstet Gynecol 112(6):1327\u20131334","journal-title":"Obstet Gynecol"},{"issue":"4","key":"11_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/jnci\/djh037","volume":"96","author":"M Arbyn","year":"2004","unstructured":"Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96(4):280\u2013293","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"11_CR10","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/jnci\/djp183","volume":"101","author":"IM Kok de","year":"2009","unstructured":"de Kok IM, van Ballegooijen M, Habbema JD (2009) Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst 101(15):1083\u20131092","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"11_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0169-2607(85)90048-3","volume":"20","author":"JD Habbema","year":"1985","unstructured":"Habbema JD, van Oortmarssen GJ, Lubbe JT, van der Maas PJ (1985) The MISCAN simulation program for the evaluation of screening for disease. Comput Methods Programs Biomed 20(1):79\u201393","journal-title":"Comput Methods Programs Biomed"},{"issue":"3","key":"11_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jnci\/94.3.193","volume":"94","author":"ME Akker-van Marle van den","year":"2002","unstructured":"van den Akker-van Marle ME, van Ballegooijen M, van Oortmarssen GJ, Boer R, Habbema JD (2002) Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst 94(3):193\u2013204","journal-title":"J Natl Cancer Inst"},{"key":"11_CR13","unstructured":"Statistics Netherlands (CBS). StatLine database (2011) ( http:\/\/statline.cbs.nl\/statweb\/?LA=en )"},{"key":"11_CR14","unstructured":"SIG (Information Centre for Health Care) (1985) Hospital diagnosis statistics 1963\u20131985. Utrecht, The Netherlands: Stichting Informatiecentrum voor de Gezondheidszorg"},{"issue":"2","key":"11_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1097-0215(20000715)87:2<221::AID-IJC11>3.0.CO;2-2","volume":"87","author":"MV Jacobs","year":"2000","unstructured":"Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N et al (2000) Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 87(2):221\u2013227","journal-title":"Int J Cancer"},{"key":"11_CR16","unstructured":"Pecorelli S, Ngan HYS, Hacker NF (2006) (Eds) Staging classifications and clinical practice guidelines for gynaecological cancers. A collaboration between FIGO and IGCS. 3rd ed. London, England: FIGO"},{"key":"11_CR17","unstructured":"van Ballegooijen M (1998) Effects and costs of cervical cancer screening [thesis]. Department of Public Health, Erasmus University Rotterdam, The Netherlands"},{"key":"11_CR18","unstructured":"European Commission. European guidelines for quality assurance in cervical cancer screening (2nd ed.) (2008). In: Arbyn M, Anttilla A, Jordan J et al. (Eds) Luxembourg: Office for Official Publications of the European Communities"},{"key":"11_CR19","doi-asserted-by":"crossref","unstructured":"Berkhof J, Coupe VM, Bogaards JA, van Kemenade FJ, Helmerhorst TJ, Snijders PJ, et al (2010) The health and economic effects of HPV DNA screening in The Netherlands. Int J Cancer Nov 1;127(9):2147\u20132158","DOI":"10.1002\/ijc.25211"},{"issue":"6","key":"11_CR20","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/01.AOG.0000263461.71732.40","volume":"109","author":"M Safaeian","year":"2007","unstructured":"Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P (2007) Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance. Obstet Gynecol 109(6):1325\u20131331","journal-title":"Obstet Gynecol"},{"key":"11_CR21","unstructured":"van Ballegooijen M, Robolj M, Essink-Bot ML, Meerding WJ, Berkers LM, Habbema JDF (2006) De effecten en kosten van het bevolkingsonderzoek naar baarmoederhalsknaker in Nederland na de herstructurering (in Dutch). Erasmus University Rotterdam, The Netherlands, afdeling Maatschappelijke Gezondheidszorg"},{"issue":"4","key":"11_CR22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ijc.22167","volume":"120","author":"M Rebolj","year":"2007","unstructured":"Rebolj M, van Ballegooijen M, Berkers LM, Habbema D (2007) Monitoring a national cancer prevention program: successful changes in cervical cancer screening in The Netherlands. Int J Cancer 120(4):806\u2013812","journal-title":"Int J Cancer"},{"key":"11_CR23","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780195108248.001.0001","volume-title":"Cost-effectiveness in Health and Medicine","author":"MR Gold","year":"1996","unstructured":"Gold MR, Siegel JE, Russel LB, Weinstein MC (1996) Cost-effectiveness in Health and Medicine. Oxford University Press, New York"},{"issue":"7","key":"11_CR24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ijc.22838","volume":"121","author":"M Rebolj","year":"2007","unstructured":"Rebolj M, Bais AG, van Ballegooijen M, Boer R, Meerding WJ, Helmerhorst TJ et al (2007) Human papillomavirus triage of women with persistent borderline or mildly dyskaryotic smears: comparison of costs and side effects of three alternative strategies. Int J Cancer 121(7):1529\u20131535","journal-title":"Int J Cancer"},{"issue":"18","key":"11_CR25","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.287.18.2372","volume":"287","author":"JS Mandelblatt","year":"2002","unstructured":"Mandelblatt JS, Lawrence WF, Womack SM, Jacobson D, Yi B, Hwang YT et al (2002) Benefits and costs of using HPV testing to screen for cervical cancer. JAMA 287(18):2372\u20132381","journal-title":"JAMA"},{"issue":"5","key":"11_CR26","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1524-4733.2004.75003.x","volume":"7","author":"HG Eichler","year":"2004","unstructured":"Eichler HG, Kong SX, Gerth WC, Mavros P, Jonsson B (2004) Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? Value Health 7(5):518\u2013528","journal-title":"Value Health"},{"issue":"5","key":"11_CR27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/dc.20283","volume":"33","author":"B Cochand-Priollet","year":"2005","unstructured":"Cochand-Priollet B, Cartier I, de Cremoux P, Le Gales C, Ziol M, Molinie V et al (2005) Cost-effectiveness of liquid-based cytology with or without hybrid-capture II HPV test compared with conventional Pap smears: a study by the French Society of Clinical Cytology. Diagn Cytopathol 33(5):338\u2013343","journal-title":"Diagn Cytopathol"},{"issue":"3","key":"11_CR28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/annonc\/mdp471","volume":"21","author":"M Arbyn","year":"2010","unstructured":"Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N et al (2010) European guidelines for quality assurance in cervical cancer screening. Second edition\u2013summary document. Ann Oncol 21(3):448\u2013458","journal-title":"Ann Oncol"},{"key":"11_CR29","doi-asserted-by":"crossref","unstructured":"Karnon J, Peters J, Platt J, Chilcott J, McGoogan E, Brewer N (2004) Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis. Health Technol Assess (Winchester, England) 8(20):iii, 1\u201378","DOI":"10.3310\/hta8200"},{"issue":"4","key":"11_CR30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1479-828X.2005.00413.x","volume":"45","author":"AM Neville","year":"2005","unstructured":"Neville AM, Quinn MA (2005) An alternative cost effectiveness analysis of ThinPrep in the Australian setting. Aust N Z J Obstet Gynaecol 45(4):289\u2013294","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2458-7-191","volume":"7","author":"WN Harrison","year":"2007","unstructured":"Harrison WN, Teale AM, Jones SP, Mohammed MA (2007) The impact of the introduction of liquid based cytology on the variation in the proportion of inadequate samples between GP practices. BMC Public Health 7:191","journal-title":"BMC Public Health"},{"issue":"2","key":"11_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2303.2006.00304.x","volume":"17","author":"R Dowie","year":"2006","unstructured":"Dowie R, Stoykova B, Crawford D, Desai M, Mather J, Morgan K et al (2006) Liquid-based cytology can improve efficiency of cervical smear readers: evidence from timing surveys in two NHS cytology laboratories. Cytopathology 17(2):65\u201372","journal-title":"Cytopathology"},{"key":"11_CR33","doi-asserted-by":"crossref","unstructured":"Castle PE, Bulten J, Confortini M, Klinkhamer P, Pellegrini A, Siebers AG, et al (2010) Age-specific patterns of unsatisfactory results for conventional Pap smears and liquid-based cytology: data from two randomised clinical trials. BJOG Aug;117(9):1067\u201373","DOI":"10.1111\/j.1471-0528.2010.02650.x"},{"key":"11_CR34","unstructured":"Kitchener HC, Blanks R, Cubie H, Desai M, Dunn G, Legood R, et al (2011) MAVARIC\u2014a comparison of automation-assisted and manual cervical screening: a randomised controlled trial. Health Technol Assess (Winchester, England) Jan;15(3):iii\u2013iv, ix\u2013xi, 1\u2013170"},{"issue":"7609","key":"11_CR35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.39219.645475.55","volume":"335","author":"E Davey","year":"2007","unstructured":"Davey E, d\u2019Assuncao J, Irwig L, Macaskill P, Chan SF, Richards A et al (2007) Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ 335(7609):31","journal-title":"BMJ"},{"issue":"2","key":"11_CR36","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dc.20600","volume":"35","author":"JM Roberts","year":"2007","unstructured":"Roberts JM, Thurloe JK, Bowditch RC, Hyne SG, Greenberg M, Clarke JM et al (2007) A three-armed trial of the ThinPrep imaging system. Diagn Cytopathol 35(2):96\u2013102","journal-title":"Diagn Cytopathol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-0011-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-012-0011-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-012-0011-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T17:58:00Z","timestamp":1714067880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-012-0011-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,17]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s10552-012-0011-1","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,17]]}}}